These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38929529)

  • 21. Novel antidiabetic drugs and cardiovascular risk: Primum non nocere.
    Bonadonna RC; Borghi C; Consoli A; Volpe M
    Nutr Metab Cardiovasc Dis; 2016 Sep; 26(9):759-66. PubMed ID: 27373139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and cardiometabolic efficacy of novel antidiabetic drugs.
    Michaud L; Seplowe M; Meir J; Aronow WS
    Expert Opin Drug Saf; 2023 Feb; 22(2):119-124. PubMed ID: 36877138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.
    Yandrapalli S; Jolly G; Horblitt A; Sanaani A; Aronow WS
    Postgrad Med; 2017 Nov; 129(8):811-821. PubMed ID: 28749197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of novel classes of glucose-lowering drugs for cardiovascular outcomes: a network meta-analysis of randomised clinical trials.
    Lin DS; Lee JK; Hung CS; Chen WJ
    Diabetologia; 2021 Dec; 64(12):2676-2686. PubMed ID: 34536085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart failure in patients with type 2 diabetes mellitus: assessment with echocardiography and effects of antihyperglycemic treatments.
    Iwakura K
    J Echocardiogr; 2019 Dec; 17(4):177-186. PubMed ID: 31617144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacology of antidiabetic drugs: What can be expected of their use?
    Scheen AJ
    Presse Med; 2023 Mar; 52(1):104158. PubMed ID: 36565754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of anti-hyperglycemic drug therapy on cardiovascular and heart failure outcomes in patients with type 2 diabetes mellitus.
    Asleh R; Sheikh-Ahmad M; Briasoulis A; Kushwaha SS
    Heart Fail Rev; 2018 May; 23(3):445-459. PubMed ID: 29270818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Approaches to the Management of Diabetes Mellitus in Patients with Coronary Artery Disease.
    Oikonomou E; Xenou M; Zakynthinos GE; Tsaplaris P; Lampsas S; Bletsa E; Gialamas I; Kalogeras K; Goliopoulou A; Gounaridi MI; Pesiridis T; Tsatsaragkou A; Vavouranakis M; Siasos G; Tousoulis D
    Curr Pharm Des; 2023; 29(23):1844-1862. PubMed ID: 37403390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Dipeptidyl Peptidase-4 Inhibitors, and Risk of Hospitalization.
    Lyu B; Grams ME; Chang A; Inker LA; Coresh J; Shin JI
    Am J Cardiol; 2022 Feb; 165():124-130. PubMed ID: 34937658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular and mortality benefits of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists as third-step glucose-lowering medicine in patients with type 2 diabetes: a retrospective cohort analysis.
    McCormick TA; Kramer J; Liles EG; Amos Q; Martin JP; Adams JL
    BMJ Open Diabetes Res Care; 2024 May; 12(3):. PubMed ID: 38719507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure: The Need for Further Evidence Generation and Practice Guidelines Optimization.
    Khan MS; Fonarow GC; McGuire DK; Hernandez AF; Vaduganathan M; Rosenstock J; Handelsman Y; Verma S; Anker SD; McMurray JJV; Kosiborod MN; Butler J
    Circulation; 2020 Sep; 142(12):1205-1218. PubMed ID: 32955939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Novel antidiabetic drugs and cardiovascular complications].
    Pareek M; Mortensen MB; Løfgren B; Nielsen ML; Olsen MH; Andersen NH
    Ugeskr Laeger; 2018 Feb; 180(6):. PubMed ID: 29429477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Systematic Review of Newer Antidiabetic Agents in the Treatment of Nonalcoholic Fatty Liver Disease.
    Dougherty JA; Guirguis E; Thornby KA
    Ann Pharmacother; 2021 Jan; 55(1):65-79. PubMed ID: 32571083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular Safety and Benefits of Noninsulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus-Part 1.
    Yandrapalli S; Jolly G; Horblitt A; Pemmasani G; Sanaani A; Aronow WS; Frishman WH
    Cardiol Rev; 2020; 28(4):177-189. PubMed ID: 32282393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular effects of antidiabetic drugs.
    Sørensen AM; Christensen MB
    Drugs Today (Barc); 2018 Sep; 54(9):547-559. PubMed ID: 30303495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Review of Cardiovascular Outcomes Trials of Glucose-Lowering Therapies and Their Effects on Heart Failure Outcomes.
    Nassif ME; Kosiborod M
    Am J Cardiol; 2019 Dec; 124 Suppl 1():S12-S19. PubMed ID: 31741435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes.
    Fitchett DH; Udell JA; Inzucchi SE
    Eur J Heart Fail; 2017 Jan; 19(1):43-53. PubMed ID: 27653447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of DPP-4 inhibitors, GLP-1 receptor agonists, SGLT-2 inhibitors and sulphonylureas on mortality, cardiovascular and renal outcomes in type 2 diabetes: A network meta-analyses-driven approach.
    Brønden A; Christensen MB; Glintborg D; Snorgaard O; Kofoed-Enevoldsen A; Madsen GK; Toft K; Kristensen JK; Højlund K; Hansen TK; Søndergaard E; Hansen KB
    Diabet Med; 2023 Aug; 40(8):e15157. PubMed ID: 37249579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evolution of type 2 diabetes management: glycemic control and beyond with SGLT-2 inhibitors and GLP-1 receptor agonists.
    Serowik TC; Pantalone KM
    J Osteopath Med; 2024 Mar; 124(3):127-135. PubMed ID: 37921061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Diabetes in Patients with Heart Failure.
    Bowes CD; Lien LF; Butler J
    Curr Cardiol Rep; 2018 Aug; 20(10):97. PubMed ID: 30151728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.